What is Lenvima (Lenvanix) Lenvatinib 10mg?
Lenvima / Lenvanix (Lenvatinib 10mg) is an oral targeted cancer therapy used for treating patients with differentiated thyroid cancer (DTC) that no longer responds to radioactive iodine treatment. It works by blocking specific enzymes responsible for tumor growth and blood vessel formation.
How Does Lenvatinib Work?
Lenvatinib is a tyrosine kinase inhibitor (TKI) that targets VEGFR, FGFR, PDGFR, KIT, and RET pathways.
By blocking these signals, it helps:
-
Slow or stop cancer cell growth
-
Reduce tumor size
-
Prevent formation of new blood vessels feeding the cancer
⭐ Key Benefits
-
Effective first-line therapy for advanced thyroid cancer
-
Helps control disease progression
-
Convenient oral capsule formulation
-
Widely recommended in oncology treatment guidelines
⭐ Indications
Lenvatinib 10mg is used for:
-
Differentiated Thyroid Cancer (Papillary, Follicular, Hurthle Cell)
-
Patients who are refractory to radioactive iodine
⭐ Dosage & Administration
-
Follow oncologist guidance strictly
-
Usually taken once daily
-
Swallow capsules whole with water
-
Can be taken with or without food
Do not adjust dose without medical supervision.
⭐ Possible Side Effects
Common side effects may include:
-
High blood pressure
-
Fatigue
-
Diarrhea
-
Weight loss
-
Loss of appetite
-
Nausea
Seek immediate medical attention if experiencing severe reactions.
⭐ Precautions
-
Not recommended during pregnancy or breastfeeding
-
Inform doctor of kidney, liver, or heart conditions
-
Monitor blood pressure regularly